Search

everythinglearnresearchcommunity

for

Search:↓

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Sorafenib can cause a temporary skin condition that goes away after stopping the drug.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Tangent screens help detect visual field defects from vigabatrin.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Tofacitinib may help regrow hair in alopecia areata patients.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Tofacitinib may help treat hair loss in children with alopecia areata.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Nobiletin-loaded vesicles effectively treat skin cancer by restoring normal miRNA and antioxidant levels.

Certain cancer drugs can cause skin issues like rashes and itching.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.